Is BHRT safe? What do doctors say about bioidentical hormones?

Short answer: Bioidentical hormone replacement therapy (BHRT) can be safe and effective for treating menopausal symptoms when prescribed and monitored appropriately — but there’s an important distinction doctors make between FDA‑approved “bioidentical” hormones and unregulated compounded BHRT. Most professional medical societies recommend FDA‑approved products and caution about compounded preparations.

Key points doctors and medical organizations say

• “Bioidentical” simply means the hormone molecule is chemically identical to the human hormone (e.g., 17β‑estradiol, micronized progesterone). That alone doesn’t guarantee safety.
• FDA‑approved bioidentical hormones (standard prescription products) have documented dosing, quality control, and clinical-trial data on benefits and risks. Clinicians generally prefer these because they are regulated and tested.
• Compounded BHRT (custom creams, troches, gels made by compounding pharmacies) lacks the same regulation and consistent dosing. Major bodies — North American Menopause Society (NAMS), American College of Obstetricians and Gynecologists (ACOG), the Endocrine Society and the FDA — warn that claims about “customized” or “safer/natural” compounded hormones are not well supported by evidence.
• Risks of hormone therapy depend on type/dose/route and patient factors (age, time since menopause, medical history). Known risks of systemic estrogen (especially combined estrogen–progestin) include increased risk of blood clots, stroke, and, with long‑term use, possible increased breast cancer risk. Transdermal estrogen may have lower clot risk than oral estrogen; micronized progesterone may have a more favorable profile than some synthetic progestins.
• Saliva hormone testing (often marketed by BHRT clinics) is unreliable for guiding dosing; most doctors do not use it for management.

Practical, doctor‑oriented guidance

• If you and your clinician decide on hormone therapy, prefer FDA‑approved, regulated products when possible (predictable dosing, safety data).
• Use the lowest effective dose for symptoms and reassess regularly.
• If you have a uterus and are taking systemic estrogen, you need an appropriate progestogen to protect the endometrium.
• Discuss personal risk factors (breast cancer history, clotting disorders, cardiovascular disease, liver disease, smoking) before starting.
• Get regular follow‑up: symptom review, screening (mammography), and labs guided by your clinician.

Specific FDA‑approved products doctors commonly use (examples)

• Estradiol (oral/transdermal/vaginal): Estrace (oral), Climara / Estraderm / Vivelle‑Dot / Alora (patches), Vagifem (vaginal tablet), Estring (vaginal ring)
• Micronized progesterone: Prometrium (oral); Crinone, Endometrin (vaginal progesterone preparations)
• Combination product: Bijuva (oral estradiol + progesterone capsule)
• Testosterone (for men: AndroGel, Testim, Androderm — for women, testosterone therapy is off‑label and used cautiously with limited evidence)

If you’re considering compounded BHRT

• Be cautious. Ask the prescriber why a compounded product is needed instead of an FDA‑approved product.
• If you still choose compounding, use a pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) or one with strong quality control, and request certificates of analysis and USP compliance.
• Expect close follow‑up and objective clinical endpoints (symptoms, safety monitoring) rather than saliva tests.

Trusted resources and organizations

• North American Menopause Society (NAMS) — position statements and patient info
• American College of Obstetricians and Gynecologists (ACOG)
• The Endocrine Society
• FDA consumer information on BHRT and compounded hormones
• Major medical centers: Mayo Clinic, Cleveland Clinic (reliable patient guides)

Bottom line BHRT can be a safe, effective option if you use evidence‑based, FDA‑approved hormones under a clinician’s supervision and with appropriate monitoring. Be skeptical of claims that compounded BHRT is inherently safer or more “natural,” and avoid saliva testing as a dosing guide. Talk with a gynecologist, endocrinologist, or a menopause specialist about which option fits your symptoms and risks.

If you’d like, tell me your age, symptoms, medical history (e.g., history of clotting, breast cancer, heart disease), and whether you’re already on any hormones — I can help summarize the pros and cons for your situation and suggest questions to ask a clinician.